Status:
COMPLETED
Standard Amblyopia Therapy in Adult Amblyopes
Lead Sponsor:
Southern California College of Optometry at Marshall B. Ketchum University
Collaborating Sponsors:
Allergan
Conditions:
Amblyopia
Eligibility:
All Genders
18+ years
Brief Summary
Amblyopia is characterized by a reduction in visual acuity, contrast sensitivity, and binocular visual functions. The two main causes of amblyopia are anisometropia and strabismus which alter the syna...
Detailed Description
Functional amblyopia is an optically uncorrectable decrease in visual acuity, i.e., spatial resolution, with no apparent pathological or morphological cause. There are several etiological origins for ...
Eligibility Criteria
Inclusion
- Amblyopic patients with acuities between 20/40 (0.30 logMAR) and 20/400 (1.30 logMAR).
- All subjects will be over the age of 18.
- Prior amblyopia therapy is not an exclusion criteria.
- Subjects will be recruited from the College community and University Eye Clinic.
Exclusion
- A significant cataract that affects vision.
- Glaucoma, diabetes, uncontrolled high blood pressure.
- Other ocular or systemic diseases that will affect visual acuity.
- The inability to give informed consent.
Key Trial Info
Start Date :
December 16 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 24 2016
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT03341780
Start Date
December 16 2014
End Date
October 24 2016
Last Update
November 17 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.